Article Details

Kronos Bio Reels In $105M for Drugs That Hit “Undruggable” Targets

Retrieved on: 2019-07-18 00:52:30

Tags for this article:

Click the tags to see associated articles and topics

Kronos Bio Reels In $105M for Drugs That Hit “Undruggable” Targets. View article details on hiswai:

Excerpt

<div>Other investors in the Kronos financing included Nextech, GV, Perceptive Advisors, Invus, and <b>Polaris Partners</b>. The company said Bischofberger as ...</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up